Your browser doesn't support javascript.
loading
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.
Wang, Hui; Zhang, Yuntao; Huang, Baoying; Deng, Wei; Quan, Yaru; Wang, Wenling; Xu, Wenbo; Zhao, Yuxiu; Li, Na; Zhang, Jin; Liang, Hongyang; Bao, Linlin; Xu, Yanfeng; Ding, Ling; Zhou, Weimin; Gao, Hong; Liu, Jiangning; Niu, Peihua; Zhao, Li; Zhen, Wei; Fu, Hui; Yu, Shouzhi; Zhang, Zhengli; Xu, Guangxue; Li, Changgui; Lou, Zhiyong; Xu, Miao; Qin, Chuan; Wu, Guizhen; Gao, George Fu; Tan, Wenjie; Yang, Xiaoming.
Afiliación
  • Wang H; Beijing Institute of Biological Products Company Limited, Beijing, China.
  • Zhang Y; Beijing Institute of Biological Products Company Limited, Beijing, China.
  • Huang B; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
  • Deng W; National Animal Models for Human Diseases Resources Center, NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Me
  • Quan Y; National Institute for Food and Drug Control, Beijing, China.
  • Wang W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
  • Xu W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
  • Zhao Y; Beijing Institute of Biological Products Company Limited, Beijing, China.
  • Li N; Beijing Institute of Biological Products Company Limited, Beijing, China.
  • Zhang J; Beijing Institute of Biological Products Company Limited, Beijing, China.
  • Liang H; Beijing Institute of Biological Products Company Limited, Beijing, China.
  • Bao L; National Animal Models for Human Diseases Resources Center, NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Me
  • Xu Y; National Animal Models for Human Diseases Resources Center, NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Me
  • Ding L; Beijing Institute of Biological Products Company Limited, Beijing, China.
  • Zhou W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
  • Gao H; National Animal Models for Human Diseases Resources Center, NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Me
  • Liu J; National Animal Models for Human Diseases Resources Center, NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Me
  • Niu P; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
  • Zhao L; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
  • Zhen W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
  • Fu H; Beijing Institute of Biological Products Company Limited, Beijing, China.
  • Yu S; Beijing Institute of Biological Products Company Limited, Beijing, China.
  • Zhang Z; Beijing Institute of Biological Products Company Limited, Beijing, China.
  • Xu G; MOE Key Laboratory of Protein Science & Collaborative Innovation Center of Biotherapy, School of Medicine, Tsinghua University, Beijing, China.
  • Li C; National Institute for Food and Drug Control, Beijing, China. Electronic address: changguili@aliyun.com.
  • Lou Z; MOE Key Laboratory of Protein Science & Collaborative Innovation Center of Biotherapy, School of Medicine, Tsinghua University, Beijing, China. Electronic address: louzy@mail.tsinghua.edu.cn.
  • Xu M; National Institute for Food and Drug Control, Beijing, China. Electronic address: xumiaobj@126.com.
  • Qin C; National Animal Models for Human Diseases Resources Center, NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Me
  • Wu G; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China. Electronic address: wugz@ivdc.chinacdc.cn.
  • Gao GF; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China. Electronic address: gaofu@chinacdc.cn.
  • Tan W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China. Electronic address: tanwj@ivdc.chinacdc.cn.
  • Yang X; Beijing Institute of Biological Products Company Limited, Beijing, China. Electronic address: yangxiaoming@sinopharm.com.
Cell ; 182(3): 713-721.e9, 2020 08 06.
Article en En | MEDLINE | ID: mdl-32778225
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Vacunas Virales / Vacunas de Productos Inactivados / Infecciones por Coronavirus / Evaluación Preclínica de Medicamentos / Pandemias / Betacoronavirus Límite: Animals Idioma: En Revista: Cell Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Vacunas Virales / Vacunas de Productos Inactivados / Infecciones por Coronavirus / Evaluación Preclínica de Medicamentos / Pandemias / Betacoronavirus Límite: Animals Idioma: En Revista: Cell Año: 2020 Tipo del documento: Article País de afiliación: China